TGTGInsighttelegram intelligenceLIVE / telegram public index
Post content
Post content
✨ Hyperliquid Strategies Files for $1B IPO with the U.S. SEC Hyperliquid Strategies has filed an S-1 registration with the U.S. SEC, aiming to raise up to $1 billion through the issuance of 160 million shares. ☄️ Proceeds from the IPO are planned to be used for purchasing $HYPE tokens, staking, and other DeFi-related activities. 😮 The company was formed through a merger between biotech firm Sonnet BioTherapeutics (listed on Nasdaq) and the SPAC fund Rorschach I LLC. Despite its name, Hyperliquid Strategies has no corporate affiliation with the Hyperliquid exchange. #News Alpha | Chat